BOVIE J-Plasma® Precise 360™ Handpiece Named ‘Innovation of the Year’ by the Society of Laparoendoscopic Surgeons (SLS)

-J-Plasma® product recognized for innovation by the SLS for third consecutive year-

CLEARWATER, Fla — (AUGUST 30, 2016) Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced that the Bovie® J-Plasma® product extension, branded the Precise 360™, has been named an “Innovation of the Year” by The Society of Laparoendoscopic Surgeons (SLS).

This J-Plasma® hand piece has an angled and rotating tip that enables surgeons access to structures that are difficult to reach using a straight laparoscopic device. J-Plasma®, Bovie’s transformational surgical product, uses helium ionization to allow surgeons to cut and coagulate with greater precision on and around delicate structures.

This marks the third consecutive year that a J-Plasma® product has been cited for innovation: in 2014, J-Plasma® product line won this distinction, and in 2015, it was given to the Bovie Ultimate™ Operating Room Generator, a product that combines J-Plasma® technology with the highest wattage monopolor and bipolor electrosurgical generator.

Commenting on this achievement, Mr. Robert L. Gershon, Chief Executive Officer said “We are proud that a third J-Plasma® product has been honored as an innovation of the year, highlighting the unique advantages of this exciting technology. The Precise 360 leverages J-Plasma®’s precision and adds flexibility in procedures on hard-to-reach structures including the culdesac and anterior abdominal wall. We are committed to developing innovative surgical devices, and appreciate this recognition from the Society of Laparoendoscopic surgeons.”

The Society of Laparoendoscopic Surgeons (SLS) is an educational, non-profit organization established to ensure the highest standards for the practice of laparoscopic, endoscopic and minimally invasive surgery. Each year, SLS recognizes the most innovative products of the past year that have a multidisciplinary application in minimally invasive surgery.

Bovie Medical will receive the recognition at the opening ceremony of SLS’ Minimally Invasive Surgery Week Annual Meeting and Endo Expo, to be held in Boston, Massachusetts, on Wednesday August, 31, 2016.

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com.

About SLS

The Society of Laparoendoscopic Surgeons was established as an educational, non-profit organization to help ensure the highest standards for the practice of laparoscopic, endoscopic and minimally invasive surgery. The Society serves surgeons from various specialties and other health professionals who are interested in advancing their expertise in the diagnostic and therapeutic uses of Laparoendoscopic and minimally invasive surgical techniques. With an international membership of over 6,000 surgeons, the organization offers a unique approach to the study and education of minimally invasive surgery by bringing together different medical specialties that use the techniques and tools of minimally invasive surgery.

 

Investor Relations:
MBS Value Partners
Hugh Collins / Jane Searle, 212-223-4632
investor.relations@boviemed.com

Top